Mark Loeb

Mark Loeb

McMaster University

H-index: 99

North America-Canada

About Mark Loeb

Mark Loeb, With an exceptional h-index of 99 and a recent h-index of 60 (since 2020), a distinguished researcher at McMaster University, specializes in the field of Infectious Diseases, Pathology and Molecular Medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

More than a decade since the latest CONSORT non-inferiority trials extension: do infectious diseases trials do enough?

WHO’s essential medicines and AWaRe: recommendations on first-and second-choice antibiotics for empiric treatment of clinical infections

Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study

Leveraging influenza virus surveillance from 2012 to 2015 to characterize the burden of respiratory syncytial virus disease in Canadian adults≥ 50 years of age hospitalized …

COVID-19 vaccine effectiveness among South Asians in Ontario: A test-negative design population-based case-control study

The Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019 (COVID-19): Molecular Diagnostic Testing

SARS-CoV-2 Exposures in a Large Gathering Event and Acquisition of COVID-19 in the Post-Vaccintion Era: A Randomized Trial is Possible During the Pandemic

Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study

Mark Loeb Information

University

Position

Professor

Citations(all)

43651

Citations(since 2020)

25327

Cited By

28155

hIndex(all)

99

hIndex(since 2020)

60

i10Index(all)

314

i10Index(since 2020)

229

Email

University Profile Page

McMaster University

Google Scholar

View Google Scholar Profile

Mark Loeb Skills & Research Interests

Infectious Diseases

Pathology and Molecular Medicine

Top articles of Mark Loeb

Title

Journal

Author(s)

Publication Date

More than a decade since the latest CONSORT non-inferiority trials extension: do infectious diseases trials do enough?

Adam S Komorowski

Carson KL Lo

Andrew K Kapoor

Marek Smieja

Mark Loeb

...

2024/2/15

WHO’s essential medicines and AWaRe: recommendations on first-and second-choice antibiotics for empiric treatment of clinical infections

Clinical Microbiology and Infection

Lorenzo Moja

Veronica Zanichelli

Dominik Mertz

Sumanth Gandra

Bernadette Cappello

...

2024/2/9

Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study

Microbiology spectrum

Darryl P Leong

Mark Loeb

Prem K Mony

Sumathy Rangarajan

Maha Mushtaha

...

2024/2/6

Leveraging influenza virus surveillance from 2012 to 2015 to characterize the burden of respiratory syncytial virus disease in Canadian adults≥ 50 years of age hospitalized …

Open Forum Infectious Diseases

May ElSherif

Melissa K Andrew

Lingyun Ye

Ardith Ambrose

Guy Boivin

...

2023/7

COVID-19 vaccine effectiveness among South Asians in Ontario: A test-negative design population-based case-control study

medRxiv

Rahul Chanchlani

Baiju Shah

Shrikant I Bangdiwala

Russell J de Souza

Jin Luo

...

2023

The Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019 (COVID-19): Molecular Diagnostic Testing

Mary K Hayden

Kimberly E Hanson

Janet A Englund

Mark J Lee

Mark Loeb

...

2023/12/19

SARS-CoV-2 Exposures in a Large Gathering Event and Acquisition of COVID-19 in the Post-Vaccintion Era: A Randomized Trial is Possible During the Pandemic

John M Conly

Mark Loeb

2023/10/5

Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study

Journal of Clinical Epidemiology

Omar Dewidar

Mostafa Bondok

Leenah Abdelrazeq

Khadija Aliyeva

Karla Solo

...

2023/9/1

The Effect of the COVID-19 Pandemic on Community Respiratory Virus Prevalence and Healthcare Utilization Related to Asthma, Chronic Obstructive Pulmonary Disease, and …

T Ho

A Shahzad

A Jones

N Raghavan

M Loeb

...

2023/5

Conduct and reporting of multivariate network meta-analyses: a scoping review

Jessica J Bartoszko

Mayra Gutiérrez García

Juan Pablo Díaz Martínez

Sergey Yegorov

Romina Brignardello-Petersen

...

2023/12/9

GloveCare: a pilot study in preparation for a cluster crossover randomized controlled trial of non-sterile glove-based care in preventing late-onset infection in the NICU

Pilot and Feasibility Studies

Sarah Khan

Kara K Tsang

Zheng Jing Hu

Beata Mostowiak

Salhab El Helou

...

2023/3/23

The impact of respiratory infections and probiotic use on the nasal microbiota of frail residents in long-term care homes

ERJ Open Research

Dawn ME Bowdish

Laura Rossi

Mark Loeb

Jennie Johnstone

Louis P Schenck

...

2023/9/1

Examining the effect of the COVID-19 pandemic on community virus prevalence and healthcare utilisation reveals that peaks in asthma, COPD and respiratory tract infection occur …

thorax

Terence Ho

Abdullah Shahzad

Aaron Jones

Natya Raghavan

Mark Loeb

...

2023/12/1

Respiratory protection: what SARS-CoV-2 has taught us

Mark Loeb

2023/8/1

Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and …

Plos one

Darryl P Leong

Ali Zhang

Jessica A Breznik

Rumi Clare

Angela Huynh

...

2023/2/15

Protocol for a longitudinal cohort study of Lyme disease with physical, mental and immunological assessment

BMJ open

Mark Loeb

Robert Brison

Jonathan Bramson

Todd Hatchette

Beate Sander

...

2023/11/1

Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers

Annals of internal medicine

Mark Loeb

Amy Bartholomew

Madiha Hashmi

Wadea Tarhuni

Mohamed Hassany

...

2022/12

NK-and T-cell granzyme B and K expression correlates with age, CMV infection and influenza vaccine-induced antibody titres in older adults

Frontiers in Aging

Chris P Verschoor

Emilie Picard

Melissa K Andrew

Laura Haynes

Mark Loeb

...

2023/1/5

Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled …

Vaccine

Henrique Pott

Melissa K Andrew

Zachary Shaffelburg

Michaela K Nichols

Lingyun Ye

...

2023/10/6

How Generalizable Are Randomized Controlled Trials (RCTs) in Staphylococcus aureus Bacteremia? A Description of the Mortality Gap Between RCTs and …

Clinical Infectious Diseases

Anthony D Bai

Carson KL Lo

Adam S Komorowski

Mallika Suresh

Kevin Guo

...

2022/10/15

See List of Professors in Mark Loeb University(McMaster University)